These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38188794)

  • 1. Retracted: Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
    International BR
    Biomed Res Int; 2023; 2023():9810949. PubMed ID: 38188794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
    Tian K; Li Z; Qin L
    Biomed Res Int; 2022; 2022():4119912. PubMed ID: 35937401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and the Relationship with CT Signs.
    Huang J; Ren K
    Contrast Media Mol Imaging; 2023; 2023():1421709. PubMed ID: 36851977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9805719. PubMed ID: 37538490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value and Clinical Significance of Combined Detection of Serum Markers CYFRA21-1, SCC Ag, NSE, CEA and ProGRP in Non-Small Cell Lung Carcinoma.
    Li Q; Sang S
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.
    Bi H; Yin L; Fang W; Song S; Wu S; Shen J
    Lab Med; 2023 Jul; 54(4):372-379. PubMed ID: 36282321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
    Liu Y; Yu L; Lin J
    Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
    Pan YW; Zhou ZG; Wang M; Dong JQ; Du KP; Li S; Liu YL; Lv PJ; Gao JB
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE and ProGRP for lung cancers of different pathological types].
    Gao J; Zhang L; Peng K; Sun H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):886-891. PubMed ID: 35790439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: CT Signs and Differential Diagnosis of Peripheral Lung Cancer and Inflammatory Pseudotumor: A Meta-Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9840635. PubMed ID: 37886330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer.
    Du J; Li Y; Wang L; Zhou Y; Shen Y; Xu F; Chen Y
    Clin Chim Acta; 2020 Oct; 509():295-303. PubMed ID: 32592711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9819261. PubMed ID: 36475011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer.
    Mehta A; Parkash A; Bhatia M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2569-2576. PubMed ID: 34452572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
    Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
    Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma.
    Giovanella L; Fontana M; Keller F; Campenni' A; Ceriani L; Paone G
    Clin Chem Lab Med; 2021 Aug; 59(9):1569-1573. PubMed ID: 33860650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of plasma pro-gastrin-releasing peptide, cytokeratin 19-fragments and carcinoembryonic antigen in patients with lung cancer].
    Chen YJ; Jin WD; Yang GY; Zhou YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):381-3. PubMed ID: 22338231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.